Helen H. Liang, PhD

September 09 2024 – 5 Notable Articles To Read Article: French femtech Sonio acquired by Samsung Electronics Takeaway: The deal is set to close after the company's second round of FDA clearance in 2024, with Sonio's reporting and workflow solution being implemented at several sites across the U.S. Source: Tech.eu Link: https://lnkd.in/daM6RfF5 Article: Sozo Ventures To Raise $500M Fund Takeaway: Founded in 2012, Sozo Ventures invests in and supports IT companies as they expand globally. The firm backs industry leaders in advanced data technologies, e-commerce, enterprise cloud, fintech, IoT, healthcare IT, and other emerging sectors. Source: VCWire Link: https://lnkd.in/dpqBYNfz Article: Exclusive - Intel Corporation CEO to pitch board on plans to shed assets, cut costs, source says Takeaway: The plan will include ideas on how to shave overall costs by selling businesses, including its programmable chip unit Altera, that Intel can no longer afford to fund from the company’s once-sizeable profit. Source: Reuters Link: https://lnkd.in/dxchSssR Article: Active ETFs set to hit $1T in assets Takeaway: The gains represent a significant rise in recent years for active ETFs, which have existed since at least 2006 but didn't reach $100B in assets until 2018, according to ETFGI data. Source: Financial Times Link: https://lnkd.in/dBkHU4RK Article: The IPO Market Will End 2024 On A Low Note Takeaway: The buyer views valuation concerns as a less significant factor holding back IPOs. After the market downturn, many former unicorns had to accept lower valuations. However, that process is largely finished, even if not everyone is satisfied with the outcome. Source: Crunchbase Link: https://lnkd.in/da26NZGp #news #research #business #ai

4

Qi Li, Physician Executive, and Nicholai Mitchko, Manager, Solution Partner Sales Engineer at InterSystems are leading a roundtable at #TechCrunchDisrupt2024 on "Leverage Data Standards to Accelerate Your Startup" 💡 Key Takeaways You Can't Afford to Miss: • Data Interoperability: Discover how standardizing data can enhance interoperability and streamline processes. • Scalability: Learn how data standards can help your startup scale efficiently and effectively. • Innovation: Explore how leveraging data standards can drive innovation and competitive. 📅 Missed it today? No worries! We're doing an encore session tomorrow from 10:50 AM to 11:20 AM at Roundtable #3! Make sure to pre-register on the event app to secure your spot. #TechCrunchDisrupt2024 #InterSystems #DataStandards #StartupGrowth #Innovation

50

1 Comment

🚨 Healthcare Tech Innovation Alert 🚨 Mendaera, Inc., a San Mateo-based healthcare tech company developing a handheld robotic interventional platform, has raised an impressive $73M in Series B funding! 💰 The round was led by Threshold Ventures, with backing from Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health, Inc.). 🏦 Mendaera is using this funding to scale robotics and AI across mainstream medical procedures, making cutting-edge technology more accessible across medical specialties and sites of service. Founded by CEO Josh DeFonzo, Mendaera’s platform integrates: • Robotics 🤖 • AI 🧠 • Real-time imaging 🖼️ • Virtual connectivity 🌐 Their goal? To empower healthcare providers and systems to meet the growing demand for needle-based interventions more efficiently. 🏥💉 In 2023, Mendaera made big moves: • Acquired telepresence technology from Avail Medsystems has moved to Mendaera, Inc. to expand its virtual connectivity portfolio 📡 •Entered into a commercial agreement with Butterfly Network, Inc., a leader in point-of-care ultrasound tech 🦋 This is just the beginning for Mendaera as they revolutionize the intersection of robotics and healthcare! 📢 Stay tuned to Future Techly for the latest updates on this groundbreaking initiative and the latest in tech and business! 💥 Source: FinSMEs #Mendaera #HealthcareInnovation #MedTech #Robotics #SeriesBFunding #AI #VirtualConnectivity #ThresholdVentures #FredMoll #TechNews #ButterflyNetwork #FutureTechly

2

Great article at TechCrunch on our new SparkLabs AIM AI Fund by Kate Park! This is an early-stage fund focused on AI startups across the globe, and part of this will be to invest in participants in our AIM-X accelerator in Riyadh. Our team greatly appreciates Ibrahim Neyaz, Abdullah M. Alhaqbani, Meshal Alkabeer, Aeshah F. Almutairi, and others at National Technology Development Program for selecting SparkLabs Saudi Arabia to run their AIM-X accelerator program and supporting us in the launch of this new AI fund. The 14 AI startups on our first batch are all excellent companies led by world-class founders. Our ever-expanding global network continues to find and attract top founders from Mumbai to Milan to Berlin to Hong Kong to Silicon Valley. The first accelerator batch in Riyadh continues to build upon the types of startups SparkLabs Group attracts, which is a range from strong bootstrapped to series B startups: - A few 1st batch companies will hit $3M, $5M and $10M in revenue for 2024. - 9 companies have raised $1.5M or more before entering our program, and 5 who have raised more than $3M prior to joining. - Great traction from hitting $1M in profit for 2024 (40% net profit) to signing 350+ enterprise clients and on track to hit $7M in revenues for 2024 to becoming cashflow positive and growing 4X in the last 12 Months ($4M+ in revenues for 2024). #startups #AI #GenAI #venturecapital #NTDP #accelerator #Riyadh #SaudiArabia #founders #entrepreneurs #chatGPT William Chu Ivan Grlic Bodin Scepanovic Sohail Alangari Scott Sorochak Rob DeMillo Lucidya | لوسيديا viAct Swirl® Contents ORKO askLAYLA Arctech Innovation OptimHire WideBot Orbo.ai Vyrill Stack Tech Farm Ahya Ideas Lab

1

𝗧𝗶𝗺 𝗛𝘄𝗮𝗻𝗴, 𝗼𝘂𝗿 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗖𝗼𝘂𝗻𝘀𝗲𝗹 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗳𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗶𝗻 Law360 𝘄𝗵𝗲𝗿𝗲 𝗵𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝘀 𝘁𝗵𝗲 𝗲𝘅𝗰𝗶𝘁𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗱𝗲𝗽𝗹𝗼𝘆𝗶𝗻𝗴 𝗲𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲-𝗴𝗿𝗮𝗱𝗲 𝗔𝗜 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲, 𝗮𝘀 𝘄𝗲𝗹𝗹 𝗮𝘀 𝘁𝗵𝗲 𝗰𝗼𝗺𝗽𝗹𝗲𝘅𝗶𝘁𝗶𝗲𝘀 𝗼𝗳 𝗺𝗮𝗸𝗶𝗻𝗴 𝗶𝘁 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 ⚖️✨ Our General Counsel, Tim Hwang, shared insights with Law360 on the importance of trust when scaling ambient AI across large healthcare systems. He emphasized how Abridge puts clinicians at the heart of everything we do: “The fact that Abridge is run by someone who still sees patients every week means that doctors are always at the center of our vision. This technology is designed to help them move faster and better.” Tim also discussed the complexities of working in a sensitive field like healthcare, highlighting the need to build tools that professionals can truly rely on to improve their day-to-day workflows and, ultimately, the quality of care they provide. 👉 Read the full interview here: https://lnkd.in/e49rR_mr

75

New Blog Post Alert! Our lead front-end engineer, Kevin Dutton, is on the blog today sharing how Serif Health customers from hospitals to ASCs and physician groups are using our price transparency platform Signal to build customized Peer Benchmark Reports - all with Serif's signature simple and beautiful user experience. Learn more about how we are working with customers track and analyze the network contracts and reimbursement rates of peers and competitor organizations over time to supercharge their contracting strategies with health plans: https://lnkd.in/gBdpTTAE If you're interesting in using our Peer Benchmark Reporting and developing a Moneyball style strategy for your healthcare organization, please schedule some time with the Serif Health team here - https://lnkd.in/gKVG2E9N

16

1 Comment

Open-source models can be a strong lever for increasing gross margins at AI companies, especially those that have hefty cost structures (e.g., enterprise sales orgs that require significant customer success or implementation resources, as well forward-deployed AI services models common in healthcare and life sciences). One of many reasons to maintain a modular and flexible stack with minimal dependencies when building an AI company. More on the importance of flexibility in the AI stack: https://lnkd.in/eA2XATRk h/t Delip Rao #ai #artificialintelligence #generativeai #healthcare

50

6 Comments

“According to Pitchbook Q1 2024, funding for telehealth and digital therapeutics was $1bn for the quarter, similar to the prior three quarters. I find interesting that the smaller VCs are the most active. Alumni Ventures was the most active digital health VC investor in the first quarter with four deals, followed by Connecticut Innovations with three deals. Since 2020, General Catalyst, Alumni Ventures, Gaingels, Optum Ventures, and City Light Capital have led digital health VC investments. Stay tuned this month for my blog post that shares ideas of new business models (despite their current modest size), and the emerging funds who invest in them. They can make a dent in the U.S. healthcare system that amounts to $4.5 trillion dollar annual spend across payors, providers, and patients. https://lnkd.in/gCxMEjt6

2

Leveraging AI to address Care Gaps and predict outcomes in Oncology - Sanjay Juneja, M.D. https://lnkd.in/dp-JS8Yx Tempus AI Eric Lefkofsky Ezra Cohen Jonathan Ozeran Chris Scotto DiVetta #Cancer #CancerCare #CancerAwareness #Medicine #Health #Oncology #OncoDaily

65

2 Comments

Generally surprised to not see more hardware vendors in healthcare and life sciences partnering with AI-first companies. When the zone of genius of a company is hardware, it's difficult to imagine that same team achieving parity on an AI product – Apple may be the greatest example of success in this realm, and still has secured many AI capabilities via targeted M&A (Siri, Turi, Xnor.ai, Voysis, Inductiv). Given the importance of leveraged distribution models in the ossified industries of healthcare and life sciences, it seems there is untapped opportunity for more hardware manufacturers to partner and co-develop AI products with startups. Control over the way data is captured and processed is critical for building high quality training data sets, which creates an interesting feedback loop between hardware companies and potential AI-first startup partners. Interested to explore this further with folks in healthcare and life sciences hardware!

150

10 Comments

In today's news of AI for Good... https://lnkd.in/gtiv2qFr "To build the new AI tool, the team used data from more than 600,000 12-lead ECGs that had been collected from patients. About half of those ECGs had normal health rhythms, while the rest had a variety of heart conditions. Giorgio Quer, Ph.D., director of artificial intelligence at Scripps Research Translational Institute, assistant professor of Digital Medicine at Scripps Research and co-senior author of the paper, then began testing which combinations of just two or three electrodes could be used for AI to fully recreate the 12-lead data."

16

1 Comment

Healthcare IT News sharing our fundraising announcement today: Hexoskin, a Montreal-based digital health and AI company developing medical-grade wearables and algorithms for health monitoring and diagnostics, is very excited to announce today an additional USD $4.2M capital raise to invest in growth, digital biomarkers research, and new AI-based digital diagnostics solutions. Investors include AQC Capital and Anges Quebec (Canada), BDC Capital (Canada), ballas invest (Europe), Deep Divers Ltd (UK), and 19 other US and Canadian private investors. Pierre-Alexandre Fournier, Hexoskin’s CEO, commented, “Hexoskin’s team has over 15 years of experience in clinical AI development and high-resolution wearable sensors. Our investors understand how our digital platform is uniquely positioned to develop a range of diagnostic tests and digital solutions that can address the needs of large populations in disease areas with large unmet needs, such as cardiac, respiratory, and rare diseases.” Hexoskin’s current wearable sensing products (Hexoskin & Astroskin) serve the clinical research, defense, and aerospace markets. Its customers, including CSA, NASA, DOD, Yale Health, Boston Children’s Hospital, and hundreds of research teams across the world, have published over 250 scientific papers with Hexoskin data. Hexoskin smart shirts are also used in pharma clinical trials, and its technology has been part of the International Space Station since 2019 to support clinical trials in space. “We are excited to team up with Hexoskin and its investors to enable its next phase of development globally,” said Laurent van Lerberghe, Co-Founder of ballas invest and former Chief Strategy Officer at Sanofi. “We have been impressed by the wealth of expertise accumulated by Hexoskin with trillions of data points, more than a hundred clinical trials, and over 250 peer-reviewed publications. Through novel higher resolution digital measures and digital biomarkers in clinical and real-world settings, Hexoskin is unlocking the possibilities of early disease detection and high-quality monitoring, hence improving treatment decisions and patients’ quality of life.” More information about the company and the announcement here: https://lnkd.in/gmDfyHbr

62

13 Comments

🌟 7 Crucial Elements for Scaling Startups to Successful Exits 🌟 Reflecting on my recent experience at the OPEN Silicon Valley Forum in Santa Clara, some of us engaged in a deep discussion on what repeatedly drives startups from inception to successful exits. Our collective experience pointed to these seven essential elements: 1️⃣ Timing is Everything: Ensure the market and technology are ready for your solution. Being too early or too late can hinder success. 2️⃣ Align with Your "Why": Success requires internal motivation. Knowing your “why” keeps you resilient and purpose-driven. 3️⃣ Master the Problem, Not Just the Product: Deep understanding of the problem is far more critical than focusing solely on a product or idea. 4️⃣ Define Culture from the Start: The first five hires set the tone. Invest in "A" players who embody the culture you envision. 5️⃣ Obsess Over User Experience: A relentless focus on user experience can make or break your product’s adoption. 6️⃣ Build for Scale from Day One: Architecting for growth is not optional—it’s essential for long-term success. 7️⃣ Map Out Your Go-to-Market Strategy Early: Before building, have a clear thesis on how to generate revenue and achieve product-market fit. These principles are tried and true across multiple industries. If you’re launching a startup or scaling a business, how do these resonate with your experience? What would you add to the list? #startups #entrepreneurship #growth #scaling #productmarketfit #OPENsiliconvalley #innovation #founders Tashfeen Suleman Amer Haider Umair Khan Junaid Qurashi Wardah Inam

34

5 Comments

What do bio and health applications mean for the next wave of AI -- specifically about compute? (I'm talking to you NVDA longs!) LifeX Ventures is hosting a super roundtable with some serious techbio leaders tomorrow along with Analog Century Management's Val Zlatev -- come hear Thomas Clozel Sean McClain Chetan Patel at 11am ET For the survey results based on asking 100 techbio CTOs and CEOs, join the call. Here, my own speculations after wrapping up the report: -- Amazon needs to have a GPU program on warp drive right now -- Nvidia needs to have a data center / cloud business in the works -- Edge AI chips are about to be everywhere -- in your watch, car, sneakers, thermostats, gene sequencers, spectroscopes -- All this compute needs way more data: expect a boom in sensors of all types -- Remember human genome moonshot that sequenced one person once? Now you can sequence your every cell one by one. Expect that for protein folding (AlphaFold was that moonshot) and other simulation uses, a full "twin" model of you, cell by cell -- Google has no angle here -- worse chips, worse cloud, worse models, worse phones / edge devices -- Specialty silicon for unique use-cases, lower-power, lower-memory are surely coming fast - like back in the day for mobile phones when Qualcomm, Broadcomm, Infineon, Mediatek, etc duked it out.

26

5 Comments

The convoluted structure of the healthcare industry and unique challenges of technology adoption give VCs with experience as clinicians and operators an advantage, says Zoi Capital co-founder Dr. Ronald Razmi. Read the story here to learn more: https://okt.to/Cxl1Lo #VCJ #VentureCapital #ArtificalIntelligence #EmergingManagers #Healthcare #NorthAmerica

1